Table 3.
Number of small-intestinal lesions per subject by capsule endoscopy at baseline and after treatment
| Baseline | Post-treatment | p value1 | |
|---|---|---|---|
| Irsogladine group |
|
|
|
| Number of mucosal breaks (mean ± SD) |
0.3 ± 0.8 |
0.5 ± 0.7 |
NS |
| Number of reddened lesions (mean ± SD) |
0.2 ± 0.4 |
0.4 ± 0.6 |
NS |
| Number of sites of bleeding (mean ± SD) |
0.0 ± 0.0 |
0.2 ± 0.5 |
NS |
| Omeprazole group |
|
|
|
| Number of mucosal breaks (mean ± SD) |
0.1 ± 0.3 |
1.9 ± 2.0 |
0.0002 |
| Number of reddened lesions (mean ± SD) |
0.6 ± 0.8 |
1.3 ± 1.7 |
NS |
| Number of sites of bleeding (mean ± SD) | 0.1 ± 0.3 | 0.3 ± 0.4 | NS |
1P-values are baseline versus post-treatment within groups.